PL3646867T3 - Kompozycja farmaceutyczna - Google Patents

Kompozycja farmaceutyczna

Info

Publication number
PL3646867T3
PL3646867T3 PL18825167.2T PL18825167T PL3646867T3 PL 3646867 T3 PL3646867 T3 PL 3646867T3 PL 18825167 T PL18825167 T PL 18825167T PL 3646867 T3 PL3646867 T3 PL 3646867T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL18825167.2T
Other languages
English (en)
Inventor
Shin Sugimoto
Akito Minamizono
Original Assignee
Kowa Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Company, Ltd. filed Critical Kowa Company, Ltd.
Publication of PL3646867T3 publication Critical patent/PL3646867T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL18825167.2T 2017-06-30 2018-06-29 Kompozycja farmaceutyczna PL3646867T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017128695 2017-06-30
PCT/JP2018/024884 WO2019004449A1 (ja) 2017-06-30 2018-06-29 医薬組成物

Publications (1)

Publication Number Publication Date
PL3646867T3 true PL3646867T3 (pl) 2025-02-17

Family

ID=64742037

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18825167.2T PL3646867T3 (pl) 2017-06-30 2018-06-29 Kompozycja farmaceutyczna

Country Status (12)

Country Link
US (1) US11406621B2 (pl)
EP (1) EP3646867B1 (pl)
JP (5) JP7104039B2 (pl)
KR (1) KR102726983B1 (pl)
CN (1) CN110831591A (pl)
ES (1) ES2989870T3 (pl)
HR (1) HRP20241476T1 (pl)
HU (1) HUE069648T2 (pl)
PL (1) PL3646867T3 (pl)
RS (1) RS66245B1 (pl)
SM (1) SMT202400478T1 (pl)
WO (1) WO2019004449A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102726983B1 (ko) * 2017-06-30 2024-11-07 교와 가부시키가이샤 의약 조성물
EP3903780A4 (en) * 2018-12-27 2023-01-18 Kowa Company, Ltd. MEDICAL DEVICE
JP2022013875A (ja) * 2020-06-30 2022-01-18 興和株式会社 医薬組成物
CN112402381B (zh) * 2020-11-19 2023-02-28 广州一品红制药有限公司 一种盐酸克林霉素棕榈酸酯颗粒组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200601272B (en) * 2003-09-03 2007-04-25 Kowa Co PPAR-activating compound and pharmaceutical composition containing same
HRP20110009T1 (hr) * 2003-09-03 2011-03-31 Kowa Co. Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži
TWI598098B (zh) * 2012-09-27 2017-09-11 興和股份有限公司 脂質異常症治療劑
TWI696462B (zh) 2013-07-10 2020-06-21 日商興和股份有限公司 非酒精性脂肪性肝疾病治療劑
CH712649A1 (fr) * 2016-07-05 2018-01-15 Hemo Plus Sàrl Centre de traitement pour des soins par hémodialyse.
KR102726983B1 (ko) 2017-06-30 2024-11-07 교와 가부시키가이샤 의약 조성물

Also Published As

Publication number Publication date
EP3646867A4 (en) 2021-03-24
JPWO2019004449A1 (ja) 2020-04-30
RS66245B1 (sr) 2024-12-31
KR20200019903A (ko) 2020-02-25
EP3646867A1 (en) 2020-05-06
JP2022082819A (ja) 2022-06-02
EP3646867C0 (en) 2024-10-09
JP7104039B2 (ja) 2022-07-20
CN110831591A (zh) 2020-02-21
JP2026015525A (ja) 2026-01-29
JP2019011324A (ja) 2019-01-24
EP3646867B1 (en) 2024-10-09
US11406621B2 (en) 2022-08-09
US20200155514A1 (en) 2020-05-21
SMT202400478T1 (it) 2025-01-14
ES2989870T3 (es) 2024-11-28
JP2024045760A (ja) 2024-04-02
HRP20241476T1 (hr) 2025-01-03
WO2019004449A1 (ja) 2019-01-03
KR102726983B1 (ko) 2024-11-07
HUE069648T2 (hu) 2025-03-28

Similar Documents

Publication Publication Date Title
IL265260B (en) pharmaceutical preparations
IL265360B (en) Pharmaceutical composition
IL269061A (en) A pharmaceutical preparation containing Selexifag
IL271986B1 (en) pharmaceutical preparation
IL262654A (en) Pharmacy preparation
IL265349A (en) Pharmaceutical composition
GB201712159D0 (en) Pharmaceutical composition
GB201705303D0 (en) Pharmaceutical compositions
PL3583943T3 (pl) Kompozycja farmaceutyczna
GB201705304D0 (en) Pharmaceutical compositions
IL272419A (en) Pharmaceutical composition
GB201719447D0 (en) Pharmaceutical composition
GB201705305D0 (en) Pharmaceutical compositions
GB201705306D0 (en) Pharmaceutical compositions
HRP20220427T8 (hr) Farmaceutski spojevi
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL271513A (en) Innovative pharmaceutical composition
IL265436B (en) Pharmacy preparation
GB201615910D0 (en) Pharmaceutical composition
GB201620519D0 (en) Pharmaceutical composition
IL265428A (en) Pharmaceutical composition
GB201708328D0 (en) Pharmaceutical composition
GB201708329D0 (en) Pharmaceutical composition